Non Invasive Blood Glucose Monitoring Devices Market Size Report 2034

Non Invasive Blood Glucose Monitoring Devices Industry Perspective:

The global non invasive blood glucose monitoring devices market size was worth around USD 34.86 million in 2024 and is predicted to grow to around USD 340.49 million by 2034, with a compound annual growth rate (CAGR) of roughly 25.60% between 2025 and 2034.

Request Free Sample

Key Insights:

• As per the analysis shared by our research analyst, the global non invasive blood glucose monitoring devices market is estimated to grow annually at a CAGR of around 25.60% over the forecast period (2025-2034)
• In terms of revenue, the global non invasive blood glucose monitoring devices market size was valued at around USD 34.86 million in 2024 and is projected to reach USD 340.49 million by 2034.
• The non invasive blood glucose monitoring devices market is projected to grow at a significant rate due to the rising number of diabetic patients worldwide.
• Based on technology, the spectroscopy segment is growing at a high rate and will continue to dominate the global market as per industry projections.
• Based on the distribution channel, the retail sales segment is anticipated to command the largest market share.
• Based on region, North America is projected to dominate the global market during the forecast period.

Non Invasive Blood Glucose Monitoring Devices Market: Overview

Non-invasive blood glucose monitoring devices are healthcare equipment that monitor blood sugar levels without using a needle or the finger-pricking method. These devices are designed to be more patient-friendly and offer enhanced safety as compared to the traditionally used invasive methods of monitoring blood glucose levels. Typically, non-invasive devices are powered by a range of technologies, such as ultrasound, optical spectroscopy, and other novel techniques, to deliver an approximate value of blood glucose levels. In recent times, the industry has witnessed an increase in the number of solutions added to the market.

However, a large number of products are still under development, pending regulatory approval from concerned authorities. One of the major advantages of non-invasive blood glucose monitoring devices is their user-friendliness. The industry growth is impacted by the growing questions over the efficiency and accuracy of these devices compared to invasive procedures. Furthermore, the high cost of non-invasive blood sugar monitoring equipment may also impact overall market expansion trends in the future.

Non Invasive Blood Glucose Monitoring Devices Market Dynamics

Growth Drivers

Rising number of diabetic patients worldwide is expected to influence the market growth rate

The global non-invasive blood glucose monitoring devices market is expected to grow due to the rising number of diabetic patients across the globe. It is a chronic condition affecting more than 537 million adults as per the International Diabetes Federation (IDF). Diabetes occurs when blood sugar, also known as blood glucose, is higher than normal. According to market research, diabetic patients are at risk of damage to their kidneys, eyes, and hearts with time. In addition, once the condition develops, it cannot be completely cured but only managed. Diabetic patients are required to continuously monitor their blood glucose levels and take appropriate medication, as well as make lifestyle adjustments.

Diabetes is classified into two types: type 1 and type 2. The former is a result of genetic factors, environmental elements, or an autoimmune reaction to a certain disease. Type 2 diabetes results from poor lifestyle as well as when the body’s cells become resistant to insulin. The growing number of people worldwide with type 1 and type 2 diabetes will create demand for novel blood sugar monitoring systems, helping them better manage the condition.

Will the growing demand for wearables and integration with wellness strategies propel the non invasive blood glucose monitoring devices market revenue?

The general public across the globe is becoming more health-conscious, especially as the number of medically-caused deaths in adults is on the rise. Health-related wearables are becoming increasingly popular among people of all ages. In addition, companies developing non-invasive blood sugar monitoring equipment are increasingly expanding into the wellness sector. They are designing products for non-medical applications, allowing end-users to obtain real-time information about critical health parameters such as blood glucose.

For instance, in December 2022, Afon Technology was granted an award of EUR 2.5 million by the European Innovation Council. The company has developed a new solution for the global non-invasive blood glucose monitoring devices market called Glucowear. The device is designed to be integrated with smartwatches, thus proving beneficial for the health-conscious population.

Restraints

Do the high cost of development and limited reimbursement policies affect the non invasive blood glucose monitoring devices market revenue?

The global non-invasive blood glucose monitoring devices industry is projected to be restricted due to the high cost of developing the equipment. Non-invasive blood sugar monitoring systems are powered by advanced technologies such as optical spectroscopy. This leads to an increase in overall expenses related to designing and producing the equipment. The average cost of a non-invasive device for monitoring blood sugar may range from USD 200 to USD 400 or more.

Furthermore, limited reimbursement policies covering expenses related to the purchase of non-invasive blood glucose monitoring devices may further restrict the greater expansion of the industry during the forecast period.

Opportunities

How will the growing launch of new products generate growth opportunities for non invasive blood glucose monitoring devices industry?

The global non invasive blood glucose monitoring devices market is expected to generate growth opportunities due to the rising launch of novel products in the market. In March 2024, the US Food & Drug Administration (FDA) announced the approval for marketing the first-ever over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is intended for use by individuals over 18 years of age who do not use insulin. It is an integrated CGM (iCGM). The system uses a wearable sensor and requires users to pair it with an application installed on their smartphones.

In January 2025, Prevent, a leading player in the market, announced its plans to launch Isaac, a non-invasive alert device designed to manage blood glucose levels. Isaac will use the user’s breath for monitoring blood sugar levels. The compact structure of the device will allow it to be worn on a lanyard or a pocket clip. In February 2024, Know Labs, Inc., a growing start-up in the non-invasive medical diagnostic technology sector, launched KnowU. It is a wearable, non-invasive CGM with proven accuracy and stability. KnowU can be worn with adhesive on the forearm or wrist, depending on patient comfort.

Challenges

Regulatory hurdles and concerns over device efficiency are challenging market growth

The global non invasive blood glucose monitoring devices industry is projected to be challenged by the growing regulatory hurdles and complexities surrounding the commercial launch of the devices. Additionally, questions have been raised over the efficiency and accuracy of non-invasive blood sugar monitoring devices. The industry faces tough competition from conventional methods of monitoring blood glucose since they have a proven track record and are more widely used in healthcare settings.

Request Free Sample

Non Invasive Blood Glucose Monitoring Devices Market: Report Scope

Non Invasive Blood Glucose Monitoring Devices Market: Segmentation

The global non invasive blood glucose monitoring devices market is segmented based on technology, end-user, distribution channel, and region.

Based on the technology, the global market divisions are thermal, ultrasonic, spectroscopy, microwave, electromagnetic, and others. In 2024, around 50.01% of the total revenue was listed in the spectroscopy segment. The growing number of diabetes-related cases worldwide is fueling the segmental revenue. Additionally, the rising demand for minimally invasive or non-invasive medical devices among patients will promote the market demand in the future. The electromagnetic segment is projected to deliver the second-highest revenue in the coming years.

Based on end-users, the global non-invasive blood glucose monitoring devices market is fragmented into home care, clinics, and hospitals.

Based on the distribution channel, the global market divisions are institutional sales, online sales, and retail sales. In 2024, more than 52% of total returns were reported in the retail sales segment. The rising demand for devices for managing blood sugar levels for medical and non-medical purposes helped the segment thrive. The online sales segment will register slower growth since the sale of devices is subject to regulatory approvals. In-person purchase of the novel equipment will generate greater revenue during the projection period.

Non Invasive Blood Glucose Monitoring Devices Market: Regional Analysis

What factors will help North America to take the lead in the non invasive blood glucose monitoring devices market during the forecast duration?

The global non-invasive blood glucose monitoring devices market will be led by North America during the forecast period. In 2024, it held prominence over 53.05% of the global revenue. A major factor contributing to regional growth is the presence of several key companies operating in the industry, which are developing safer and more accurate products. Furthermore, the growing number of diabetic patients across North America as a result of sedentary lifestyles and eating habits has created demand for non-invasive medical equipment for measuring blood sugar levels. During the forecast period, a greater number of FDA approvals can be expected, which will further support the region's growth.

Europe will emerge as the second-leading market in the non invasive blood glucose monitoring devices industry. The growing health consciousness among the general public, as well as the growing elderly population, will fuel regional demand. Additionally, Europe has registered increased investments in novel medical technologies, such as non-invasive blood glucose monitoring solutions, contributing to Europe’s growth rate. The regional acceptance rate of the latest technologies, especially those related to health, has also been high over the years, directly influencing regional demand for needless blood glucose monitoring devices.

Non Invasive Blood Glucose Monitoring Devices Market: Competitive Analysis

The global non invasive blood glucose monitoring devices market is led by players like:

• Integrity Applications
• Abbott Laboratories
• Roche Diagnostics
• Know Labs Inc.
• Occuity Ltd.
• LifePlus Inc.
• Medtronic Plc
• Meta Materials Inc.
• Afon Technology Ltd.
• Dexcom Inc.
• BLUESEMI
• Nemaura Medical
• Cnoga Medical
• DiaMonTech GmbH
• NovioSense BV.

The global non invasive blood glucose monitoring devices market is segmented as follows:

By Technology

• Thermal
• Ultrasonic
• Spectroscopy
• Microwave
• Electromagnetic
• Others

By End-User

• Homecare
• Clinics
• Hospitals

By Distribution Channel

• Institutional Sales
• Online Sales
• Retail Sales

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa